{"id": "article-140077_0", "title": "Ocular Sarcoidosis -- Continuing Education Activity", "content": "Sarcoidosis is a chronic multisystemic granulomatous disorder characterized by the accumulation of non-caseating granulomas in the involved tissues. Patients with ocular sarcoidosis present with a myriad of clinical features such as uveitis, conjunctival nodules, eyelid thickening, orbital inflammation, and facial nerve palsy. This activity reviews the evaluation and treatment of ocular sarcoidosis and highlights the role of the interprofessional team in evaluating and treating patients with this condition.", "contents": "Ocular Sarcoidosis -- Continuing Education Activity. Sarcoidosis is a chronic multisystemic granulomatous disorder characterized by the accumulation of non-caseating granulomas in the involved tissues. Patients with ocular sarcoidosis present with a myriad of clinical features such as uveitis, conjunctival nodules, eyelid thickening, orbital inflammation, and facial nerve palsy. This activity reviews the evaluation and treatment of ocular sarcoidosis and highlights the role of the interprofessional team in evaluating and treating patients with this condition."}
{"id": "article-140077_1", "title": "Ocular Sarcoidosis -- Continuing Education Activity", "content": "Objectives: Describe the pathogenesis of ocular sarcoidosis. Summarize the relevant history of patients with ocular sarcoidosis. Review the evaluation process of patients with ocular sarcoidosis. Outline the management of ocular sarcoidosis, including the role of interprofessional care of these patients. Access free multiple choice questions on this topic.", "contents": "Ocular Sarcoidosis -- Continuing Education Activity. Objectives: Describe the pathogenesis of ocular sarcoidosis. Summarize the relevant history of patients with ocular sarcoidosis. Review the evaluation process of patients with ocular sarcoidosis. Outline the management of ocular sarcoidosis, including the role of interprofessional care of these patients. Access free multiple choice questions on this topic."}
{"id": "article-140077_2", "title": "Ocular Sarcoidosis -- Introduction", "content": "Sarcoidosis is a chronic multisystemic granulomatous disorder characterized by the accumulation of non-caseating granulomas in the involved tissues. Ocular sarcoidosis is an inflammatory condition that can involve any part of the eye leading to conjunctival granuloma, episcleritis/scleritis, uveitis, optic neuropathy, and/ or its adnexal tissues leading to lacrimal gland enlargement and orbital inflammation. [1]", "contents": "Ocular Sarcoidosis -- Introduction. Sarcoidosis is a chronic multisystemic granulomatous disorder characterized by the accumulation of non-caseating granulomas in the involved tissues. Ocular sarcoidosis is an inflammatory condition that can involve any part of the eye leading to conjunctival granuloma, episcleritis/scleritis, uveitis, optic neuropathy, and/ or its adnexal tissues leading to lacrimal gland enlargement and orbital inflammation. [1]"}
{"id": "article-140077_3", "title": "Ocular Sarcoidosis -- Introduction", "content": "The clinical course shows variability. Few patients may have acute self-limited disease, while others experience chronic, progressive deterioration. Corticosteroids remain the mainstay of treatment with the newer addition of immunosuppressants and biologics in the treatment armamentarium.", "contents": "Ocular Sarcoidosis -- Introduction. The clinical course shows variability. Few patients may have acute self-limited disease, while others experience chronic, progressive deterioration. Corticosteroids remain the mainstay of treatment with the newer addition of immunosuppressants and biologics in the treatment armamentarium."}
{"id": "article-140077_4", "title": "Ocular Sarcoidosis -- Etiology", "content": "The etiology of sarcoidosis remains unknown, but evidence has pointed to various infective, non-infective, and genetic factors.", "contents": "Ocular Sarcoidosis -- Etiology. The etiology of sarcoidosis remains unknown, but evidence has pointed to various infective, non-infective, and genetic factors."}
{"id": "article-140077_5", "title": "Ocular Sarcoidosis -- Etiology", "content": "Infective etiology \u2013 The presence of bacterial DNA fragments in sarcoid granulomas\u00a0and regional granulomatous response following inoculation of sarcoid material in experimental animals suggests infective etiology. [2] Few cases of transmission of cases of sarcoidosis post organ transplantation suggest the presence of a transmissible agent. [3] One hypothesis has suggested that tuberculosis and sarcoidosis may be the 'opposite ends of the same disease spectrum.' [4]", "contents": "Ocular Sarcoidosis -- Etiology. Infective etiology \u2013 The presence of bacterial DNA fragments in sarcoid granulomas\u00a0and regional granulomatous response following inoculation of sarcoid material in experimental animals suggests infective etiology. [2] Few cases of transmission of cases of sarcoidosis post organ transplantation suggest the presence of a transmissible agent. [3] One hypothesis has suggested that tuberculosis and sarcoidosis may be the 'opposite ends of the same disease spectrum.' [4]"}
{"id": "article-140077_6", "title": "Ocular Sarcoidosis -- Etiology", "content": "The\u00a0similarities in clinical features, epidemiology, immunological, and molecular link between the two diseases, and similar immune response may support the hypothesis. [4] Molecular studies have suggested the role of Mycobacterium\u00a0or Propionibacterium\u00a0in the causation of sarcoidosis. [5]", "contents": "Ocular Sarcoidosis -- Etiology. The\u00a0similarities in clinical features, epidemiology, immunological, and molecular link between the two diseases, and similar immune response may support the hypothesis. [4] Molecular studies have suggested the role of Mycobacterium\u00a0or Propionibacterium\u00a0in the causation of sarcoidosis. [5]"}
{"id": "article-140077_7", "title": "Ocular Sarcoidosis -- Etiology", "content": "Non-infective etiology \u2013 Sarcoidosis with pulmonary manifestation is known to occur as an occupational disease. [6] [7] It is thought to occur secondary to air-borne organic and nonorganic dust exposure. [8] [9]", "contents": "Ocular Sarcoidosis -- Etiology. Non-infective etiology \u2013 Sarcoidosis with pulmonary manifestation is known to occur as an occupational disease. [6] [7] It is thought to occur secondary to air-borne organic and nonorganic dust exposure. [8] [9]"}
{"id": "article-140077_8", "title": "Ocular Sarcoidosis -- Etiology", "content": "Genetic factor \u2013 Association between sarcoidosis and certain human leukocyte antigen haplotypes support the role of genetic factors. HLA-DRB1*1101 allele is associated with sarcoidosis and has a population-attributable risk of 9% in whites and 16% in blacks. [10] Greater prevalence of the disease in certain sibling pairs or parent-offspring pairs suggests genetic factors to be as important as environmental factors. [11] Siblings have a five times higher chance of developing sarcoidosis. [12] [13]", "contents": "Ocular Sarcoidosis -- Etiology. Genetic factor \u2013 Association between sarcoidosis and certain human leukocyte antigen haplotypes support the role of genetic factors. HLA-DRB1*1101 allele is associated with sarcoidosis and has a population-attributable risk of 9% in whites and 16% in blacks. [10] Greater prevalence of the disease in certain sibling pairs or parent-offspring pairs suggests genetic factors to be as important as environmental factors. [11] Siblings have a five times higher chance of developing sarcoidosis. [12] [13]"}
{"id": "article-140077_9", "title": "Ocular Sarcoidosis -- Epidemiology", "content": "The prevalence of sarcoidosis varies from region to region due to differences in case definition, asymptomatic nature of the disease, limited population screening, and ascertainment bias. In the United States, the age-adjusted incidence is reportedly three times higher in Blacks than Whites. [14]", "contents": "Ocular Sarcoidosis -- Epidemiology. The prevalence of sarcoidosis varies from region to region due to differences in case definition, asymptomatic nature of the disease, limited population screening, and ascertainment bias. In the United States, the age-adjusted incidence is reportedly three times higher in Blacks than Whites. [14]"}
{"id": "article-140077_10", "title": "Ocular Sarcoidosis -- Epidemiology", "content": "In a recent study by Baughman et al., the incidence of sarcoidosis in the United States ranged from 8.1 per 100,000 in\u00a0White race individuals to 17.8 in African Americans. [15] Northern European countries have the highest prevalence of sarcoidosis (40 in 100,000 population). [16] The prevalence of ocular features in cases of systemic sarcoidosis ranges from 12 to 76%.\u00a0Uveitis is the most frequent ocular manifestation. In patients with systemic sarcoidosis, females (56%) were more commonly noted to develop ocular symptoms than men (23%) in patients with biopsy-proven sarcoidosis. [17]", "contents": "Ocular Sarcoidosis -- Epidemiology. In a recent study by Baughman et al., the incidence of sarcoidosis in the United States ranged from 8.1 per 100,000 in\u00a0White race individuals to 17.8 in African Americans. [15] Northern European countries have the highest prevalence of sarcoidosis (40 in 100,000 population). [16] The prevalence of ocular features in cases of systemic sarcoidosis ranges from 12 to 76%.\u00a0Uveitis is the most frequent ocular manifestation. In patients with systemic sarcoidosis, females (56%) were more commonly noted to develop ocular symptoms than men (23%) in patients with biopsy-proven sarcoidosis. [17]"}
{"id": "article-140077_11", "title": "Ocular Sarcoidosis -- Epidemiology", "content": "The usual age at presentation of sarcoidosis is 20\u00a0to 50 years. However, sarcoidosis is an important cause of uveitis after 60 years of age. Sarcoidosis accounts for around 10% of all uveitides. [18] Late-onset\u00a0sarcoidosis\u00a0(diagnosis at a minimum age of 65 years) is more likely associated with uveitis, asthenia, and skin lesions.\u00a0Such patients may have a lower likelihood of erythema nodosum and asymptomatic chest X-ray abnormalities, and salivary glands biopsy may be particularly helpful in the diagnosis. [19]", "contents": "Ocular Sarcoidosis -- Epidemiology. The usual age at presentation of sarcoidosis is 20\u00a0to 50 years. However, sarcoidosis is an important cause of uveitis after 60 years of age. Sarcoidosis accounts for around 10% of all uveitides. [18] Late-onset\u00a0sarcoidosis\u00a0(diagnosis at a minimum age of 65 years) is more likely associated with uveitis, asthenia, and skin lesions.\u00a0Such patients may have a lower likelihood of erythema nodosum and asymptomatic chest X-ray abnormalities, and salivary glands biopsy may be particularly helpful in the diagnosis. [19]"}
{"id": "article-140077_12", "title": "Ocular Sarcoidosis -- Epidemiology", "content": "Children with age less than five years (early-onset sarcoidosis) have a\u00a0triad of skin disease (rashes), uveitis, and arthritis\u00a0and usually do not have\u00a0lung disease. Older children have a multisystemic involvement similar to adults with bilateral hilar lymphadenopathy and lung involvement. [20]", "contents": "Ocular Sarcoidosis -- Epidemiology. Children with age less than five years (early-onset sarcoidosis) have a\u00a0triad of skin disease (rashes), uveitis, and arthritis\u00a0and usually do not have\u00a0lung disease. Older children have a multisystemic involvement similar to adults with bilateral hilar lymphadenopathy and lung involvement. [20]"}
{"id": "article-140077_13", "title": "Ocular Sarcoidosis -- Pathophysiology", "content": "Sarcoidosis is an inflammatory disease that, in sequence, involves the activation of antigen-driven CD4+ T lymphocytes, chemokine-induced migration of T cells to the disease site, local macrophage accumulation, and granuloma formation. [21]", "contents": "Ocular Sarcoidosis -- Pathophysiology. Sarcoidosis is an inflammatory disease that, in sequence, involves the activation of antigen-driven CD4+ T lymphocytes, chemokine-induced migration of T cells to the disease site, local macrophage accumulation, and granuloma formation. [21]"}
{"id": "article-140077_14", "title": "Ocular Sarcoidosis -- Pathophysiology", "content": "In cases with active sarcoidosis, there is dominant expression of interferon \u03b3 (IFN \u03b3), interleukin (IL)-2, IL-12, and tumor necrosis alpha (TNF \u03b1) at the disease site. TNF\u03b1 is the key granuloma-promoting cytokine. [21] The CD4:CD8 ratio is increased (more than 3.5) in the bronchoalveolar lavage fluid in sarcoidosis. [22]", "contents": "Ocular Sarcoidosis -- Pathophysiology. In cases with active sarcoidosis, there is dominant expression of interferon \u03b3 (IFN \u03b3), interleukin (IL)-2, IL-12, and tumor necrosis alpha (TNF \u03b1) at the disease site. TNF\u03b1 is the key granuloma-promoting cytokine. [21] The CD4:CD8 ratio is increased (more than 3.5) in the bronchoalveolar lavage fluid in sarcoidosis. [22]"}
{"id": "article-140077_15", "title": "Ocular Sarcoidosis -- Histopathology", "content": "The formation of non-caseating (non-necrotizing) granuloma is the pathologic hallmark of sarcoidosis. [23] Granulomas are characterized by a collection of mononuclear cells and macrophages, which differentiate into epithelioid cells and multinucleated giant cells and are surrounded by an accumulation of lymphocytes, fibroblasts, collagen, and plasma cells. Asteroid bodies are star-shaped structures within the cytoplasm. Schaumann bodies (conchoidal bodies) are basophilic laminated calcified nodules seen within the multinucleated giant cells. [24] Histological evidence of infection or foreign body is usually not seen.", "contents": "Ocular Sarcoidosis -- Histopathology. The formation of non-caseating (non-necrotizing) granuloma is the pathologic hallmark of sarcoidosis. [23] Granulomas are characterized by a collection of mononuclear cells and macrophages, which differentiate into epithelioid cells and multinucleated giant cells and are surrounded by an accumulation of lymphocytes, fibroblasts, collagen, and plasma cells. Asteroid bodies are star-shaped structures within the cytoplasm. Schaumann bodies (conchoidal bodies) are basophilic laminated calcified nodules seen within the multinucleated giant cells. [24] Histological evidence of infection or foreign body is usually not seen."}
{"id": "article-140077_16", "title": "Ocular Sarcoidosis -- History and Physical", "content": "Sarcoidosis is a multisystem disease that predominantly involves lungs and thoracic lymph nodes. Patients may present with cough, dyspnea, and chest pain. Upper respiratory tract involvement leads to nonspecific rhinitis, recurrent sinusitis, and destructive lesions of the nasal septum and turbinates. Cutaneous manifestations include papules, nodules, plaques, ulcers, and erythema nodosum. [25]", "contents": "Ocular Sarcoidosis -- History and Physical. Sarcoidosis is a multisystem disease that predominantly involves lungs and thoracic lymph nodes. Patients may present with cough, dyspnea, and chest pain. Upper respiratory tract involvement leads to nonspecific rhinitis, recurrent sinusitis, and destructive lesions of the nasal septum and turbinates. Cutaneous manifestations include papules, nodules, plaques, ulcers, and erythema nodosum. [25]"}
{"id": "article-140077_17", "title": "Ocular Sarcoidosis -- History and Physical", "content": "Cardiac involvement leads to the development of arrhythmias and heart blocks. [26] Neurosarcoidosis occurs in about 5 to 10% of patients with sarcoidosis, with predominant involvement of basal leptomeninges and cranial nerves. [27]", "contents": "Ocular Sarcoidosis -- History and Physical. Cardiac involvement leads to the development of arrhythmias and heart blocks. [26] Neurosarcoidosis occurs in about 5 to 10% of patients with sarcoidosis, with predominant involvement of basal leptomeninges and cranial nerves. [27]"}
{"id": "article-140077_18", "title": "Ocular Sarcoidosis -- History and Physical", "content": "Ocular involvement in sarcoidosis is characterized by granulomatous inflammation of the eye and its adnexal tissues. Ocular involvement is the presenting feature in 30 to 40% of cases. [28] The most common ocular features are uveitis (seen in 30 to 70%)\u00a0and conjunctival nodules (seen in 40%). [29] [1]", "contents": "Ocular Sarcoidosis -- History and Physical. Ocular involvement in sarcoidosis is characterized by granulomatous inflammation of the eye and its adnexal tissues. Ocular involvement is the presenting feature in 30 to 40% of cases. [28] The most common ocular features are uveitis (seen in 30 to 70%)\u00a0and conjunctival nodules (seen in 40%). [29] [1]"}
{"id": "article-140077_19", "title": "Ocular Sarcoidosis -- History and Physical -- Orbital Disease", "content": "Involvement of orbital structures such as orbital fat, extraocular muscles, and optic nerve sheath leads to proptosis, globe displacement, pain, vision loss, and diplopia. [30] Most orbital lesions are located in the anterior orbit, especially the anteroinferior quadrant. [31] Orbital mass secondary to sarcoidosis can cause compression of the central retinal artery leading to central retinal artery occlusion (CRAO). [32]", "contents": "Ocular Sarcoidosis -- History and Physical -- Orbital Disease. Involvement of orbital structures such as orbital fat, extraocular muscles, and optic nerve sheath leads to proptosis, globe displacement, pain, vision loss, and diplopia. [30] Most orbital lesions are located in the anterior orbit, especially the anteroinferior quadrant. [31] Orbital mass secondary to sarcoidosis can cause compression of the central retinal artery leading to central retinal artery occlusion (CRAO). [32]"}
{"id": "article-140077_20", "title": "Ocular Sarcoidosis -- History and Physical -- Lacrimal System Disease", "content": "Keratoconjunctivitis sicca (KCS) is a common manifestation of ocular sarcoidosis. [33] Patients with keratoconjunctivitis sicca present with ocular irritation, epiphora, corneal infiltrate,\u00a0corneal infection,\u00a0and corneal scar. Inflammation of the lacrimal gland leads to enlargement of the gland with mass effects, proptosis, and dry eye syndrome (KCS) secondary to decreased aqueous production. [30] Inflammation of nasolacrimal sac and lacrimal drainage system leads to obstruction of tear outflow with epiphora, pain, and pus pointing secondary to dacryocystitis. [34]", "contents": "Ocular Sarcoidosis -- History and Physical -- Lacrimal System Disease. Keratoconjunctivitis sicca (KCS) is a common manifestation of ocular sarcoidosis. [33] Patients with keratoconjunctivitis sicca present with ocular irritation, epiphora, corneal infiltrate,\u00a0corneal infection,\u00a0and corneal scar. Inflammation of the lacrimal gland leads to enlargement of the gland with mass effects, proptosis, and dry eye syndrome (KCS) secondary to decreased aqueous production. [30] Inflammation of nasolacrimal sac and lacrimal drainage system leads to obstruction of tear outflow with epiphora, pain, and pus pointing secondary to dacryocystitis. [34]"}
{"id": "article-140077_21", "title": "Ocular Sarcoidosis -- History and Physical -- Eyelid and Ocular Surface Disease", "content": "Eyelid - Erythematous eyelid swelling is seen in ocular sarcoidosis, which can vary in size from small papules to a large mass. [35] Granulomatous inflammation of eyelids can lead to ptosis, entropion, trichiasis, and madarosis. [36] Selective involvement of M\u00fcller's muscle may lead to eyelid retraction. [37]", "contents": "Ocular Sarcoidosis -- History and Physical -- Eyelid and Ocular Surface Disease. Eyelid - Erythematous eyelid swelling is seen in ocular sarcoidosis, which can vary in size from small papules to a large mass. [35] Granulomatous inflammation of eyelids can lead to ptosis, entropion, trichiasis, and madarosis. [36] Selective involvement of M\u00fcller's muscle may lead to eyelid retraction. [37]"}
{"id": "article-140077_22", "title": "Ocular Sarcoidosis -- History and Physical -- Eyelid and Ocular Surface Disease", "content": "Conjunctiva - Conjunctival nodules are seen as white discrete conjunctival deposits predominantly affecting bulbar conjunctiva but can also be seen in the perilimbal area and palpebral conjunctiva. [38] In some conditions, the conjunctival nodules mimic acute follicular conjunctivitis. [39] Complications include the development of symblepharon secondary to chronic cicatricial inflammation. [40] Sclera \u2013 Scleritis is a rare manifestation of ocular sarcoidosis\u00a0and can manifest as diffuse anterior, nodular anterior, or posterior scleritis. [41] [42]", "contents": "Ocular Sarcoidosis -- History and Physical -- Eyelid and Ocular Surface Disease. Conjunctiva - Conjunctival nodules are seen as white discrete conjunctival deposits predominantly affecting bulbar conjunctiva but can also be seen in the perilimbal area and palpebral conjunctiva. [38] In some conditions, the conjunctival nodules mimic acute follicular conjunctivitis. [39] Complications include the development of symblepharon secondary to chronic cicatricial inflammation. [40] Sclera \u2013 Scleritis is a rare manifestation of ocular sarcoidosis\u00a0and can manifest as diffuse anterior, nodular anterior, or posterior scleritis. [41] [42]"}
{"id": "article-140077_23", "title": "Ocular Sarcoidosis -- History and Physical -- Eyelid and Ocular Surface Disease", "content": "Cornea \u2013 The most common corneal manifestation of ocular sarcoidosis is superficial punctate keratitis secondary to dry eye (keratoconjunctivitis sicca). Other manifestations include band-shaped keratopathy, peripheral ulcerative keratitis,\u00a0and interstitial keratitis. [43] [44] [45]", "contents": "Ocular Sarcoidosis -- History and Physical -- Eyelid and Ocular Surface Disease. Cornea \u2013 The most common corneal manifestation of ocular sarcoidosis is superficial punctate keratitis secondary to dry eye (keratoconjunctivitis sicca). Other manifestations include band-shaped keratopathy, peripheral ulcerative keratitis,\u00a0and interstitial keratitis. [43] [44] [45]"}
{"id": "article-140077_24", "title": "Ocular Sarcoidosis -- History and Physical -- Uveitis", "content": "The mean age of presentation of uveitis is 42 years.\u00a0Most sarcoid uveitis is bilateral, and approximately 90% are chronic. [46] Uveitis associated with sarcoidosis can be anterior, intermediate, posterior, or panuveitis.", "contents": "Ocular Sarcoidosis -- History and Physical -- Uveitis. The mean age of presentation of uveitis is 42 years.\u00a0Most sarcoid uveitis is bilateral, and approximately 90% are chronic. [46] Uveitis associated with sarcoidosis can be anterior, intermediate, posterior, or panuveitis."}
{"id": "article-140077_25", "title": "Ocular Sarcoidosis -- History and Physical -- Uveitis", "content": "Anterior uveitis \u2013 The patient presents with eye pain, redness of eyes, blurred vision, and photophobia. Sarcoidosis is characterized by granulomatous uveitis, with mutton fat keratic precipitates [figure 1], iris, or trabecular meshwork nodules.\u00a0Busacca nodules are noted in the iris stroma, and the Koeppe nodules involve the pupillary margin. Berlin nodules are\u00a0present at the angle of the anterior chamber. Hypopyon is usually not seen in sarcoidosis. [47]", "contents": "Ocular Sarcoidosis -- History and Physical -- Uveitis. Anterior uveitis \u2013 The patient presents with eye pain, redness of eyes, blurred vision, and photophobia. Sarcoidosis is characterized by granulomatous uveitis, with mutton fat keratic precipitates [figure 1], iris, or trabecular meshwork nodules.\u00a0Busacca nodules are noted in the iris stroma, and the Koeppe nodules involve the pupillary margin. Berlin nodules are\u00a0present at the angle of the anterior chamber. Hypopyon is usually not seen in sarcoidosis. [47]"}
{"id": "article-140077_26", "title": "Ocular Sarcoidosis -- History and Physical -- Uveitis", "content": "Without appropriate treatment, there is a development of peripheral anterior synechiae with raised intraocular pressure or posterior synechiae with complicated cataracts. Patients with ocular sarcoid uveitis tend to develop raised intraocular pressure due to outflow obstruction due to trabecular meshwork block by inflammatory cells, trabecular meshwork nodules, or development of peripheral anterior synechiae. [48]", "contents": "Ocular Sarcoidosis -- History and Physical -- Uveitis. Without appropriate treatment, there is a development of peripheral anterior synechiae with raised intraocular pressure or posterior synechiae with complicated cataracts. Patients with ocular sarcoid uveitis tend to develop raised intraocular pressure due to outflow obstruction due to trabecular meshwork block by inflammatory cells, trabecular meshwork nodules, or development of peripheral anterior synechiae. [48]"}
{"id": "article-140077_27", "title": "Ocular Sarcoidosis -- History and Physical -- Uveitis", "content": "Intermediate uveitis \u2013 Patients complain of either floaters or blurred vision. The most common cause of vision loss is the development of cystoid macular edema or vitreous inflammation. Inflammation of pars plana leads to the development of snowballs in the inferior vitreous and snow banking near ora serrata. [49] Neovascularization may develop in the peripheral retina leading to vitreous hemorrhage in a few patients. [50] The vitreous may show the string of pearls appearance.", "contents": "Ocular Sarcoidosis -- History and Physical -- Uveitis. Intermediate uveitis \u2013 Patients complain of either floaters or blurred vision. The most common cause of vision loss is the development of cystoid macular edema or vitreous inflammation. Inflammation of pars plana leads to the development of snowballs in the inferior vitreous and snow banking near ora serrata. [49] Neovascularization may develop in the peripheral retina leading to vitreous hemorrhage in a few patients. [50] The vitreous may show the string of pearls appearance."}
{"id": "article-140077_28", "title": "Ocular Sarcoidosis -- History and Physical -- Uveitis", "content": "Posterior uveitis \u2013 Choroidal inflammation leads to the development of choroidal granulomas, which may be unifocal or multifocal, and vary in size from small (like Dalen-Fuchs nodules) to significant (like choroidal tumors). [51] Inflammatory new vessels of the optic disc or the retina may cause vitreous hemorrhage. [52]", "contents": "Ocular Sarcoidosis -- History and Physical -- Uveitis. Posterior uveitis \u2013 Choroidal inflammation leads to the development of choroidal granulomas, which may be unifocal or multifocal, and vary in size from small (like Dalen-Fuchs nodules) to significant (like choroidal tumors). [51] Inflammatory new vessels of the optic disc or the retina may cause vitreous hemorrhage. [52]"}
{"id": "article-140077_29", "title": "Ocular Sarcoidosis -- History and Physical -- Uveitis", "content": "Choroidal neovascularization may develop from choroidal granulomas, which affect vision when present in the posterior pole. Mid peripheral periphlebitis is characteristic of ocular sarcoidosis.\u00a0Occlusive vasculitis causing capillary nonperfusion and retinal new vessels may also occur. In severe cases, whitish-yellow perivascular exudates are seen along the retinal veins, classically described as \"candle-wax drippings\" or taches de bougie [Figure 2]. [53] Posterior uveitis is complicated with the development of cystoid macular edema, epiretinal membrane formation, intraretinal hemorrhage, and vitreous hemorrhage.", "contents": "Ocular Sarcoidosis -- History and Physical -- Uveitis. Choroidal neovascularization may develop from choroidal granulomas, which affect vision when present in the posterior pole. Mid peripheral periphlebitis is characteristic of ocular sarcoidosis.\u00a0Occlusive vasculitis causing capillary nonperfusion and retinal new vessels may also occur. In severe cases, whitish-yellow perivascular exudates are seen along the retinal veins, classically described as \"candle-wax drippings\" or taches de bougie [Figure 2]. [53] Posterior uveitis is complicated with the development of cystoid macular edema, epiretinal membrane formation, intraretinal hemorrhage, and vitreous hemorrhage."}
{"id": "article-140077_30", "title": "Ocular Sarcoidosis -- History and Physical -- Neuro-ophthalmic Manifestations", "content": "The optic nerve and facial nerve are the most commonly affected nerves in ocular sarcoidosis. [54] Involvement of the optic nerve leads to the development of optic nerve granuloma [figure 3],\u00a0optic disc edema, and optic atrophy. Optic disc edema is secondary to either posterior uveitis, direct involvement of optic nerve, optic nerve sheath infiltration by granulomatous tissue, or secondary to raised intracranial pressure due to neurosarcoidosis. [55] [56]", "contents": "Ocular Sarcoidosis -- History and Physical -- Neuro-ophthalmic Manifestations. The optic nerve and facial nerve are the most commonly affected nerves in ocular sarcoidosis. [54] Involvement of the optic nerve leads to the development of optic nerve granuloma [figure 3],\u00a0optic disc edema, and optic atrophy. Optic disc edema is secondary to either posterior uveitis, direct involvement of optic nerve, optic nerve sheath infiltration by granulomatous tissue, or secondary to raised intracranial pressure due to neurosarcoidosis. [55] [56]"}
{"id": "article-140077_31", "title": "Ocular Sarcoidosis -- History and Physical -- Neuro-ophthalmic Manifestations", "content": "Some patients may complain of visual hallucinations,\u00a0nystagmus,\u00a0and pupillary abnormalities such as relative afferent pupillary defect or light near dissociation due to the involvement of optic pathways. [57] [58]", "contents": "Ocular Sarcoidosis -- History and Physical -- Neuro-ophthalmic Manifestations. Some patients may complain of visual hallucinations,\u00a0nystagmus,\u00a0and pupillary abnormalities such as relative afferent pupillary defect or light near dissociation due to the involvement of optic pathways. [57] [58]"}
{"id": "article-140077_32", "title": "Ocular Sarcoidosis -- History and Physical -- Neuro-ophthalmic Manifestations", "content": "Facial nerve involvement leads to lower motor neuron facial paresis leading to epiphora, exposure keratopathy, and corneal ulcers. Facial nerve involvement occurs due to inflammation in the parotid gland or secondary to meningitic reaction or direct compression of the facial nerve. [59]", "contents": "Ocular Sarcoidosis -- History and Physical -- Neuro-ophthalmic Manifestations. Facial nerve involvement leads to lower motor neuron facial paresis leading to epiphora, exposure keratopathy, and corneal ulcers. Facial nerve involvement occurs due to inflammation in the parotid gland or secondary to meningitic reaction or direct compression of the facial nerve. [59]"}
{"id": "article-140077_33", "title": "Ocular Sarcoidosis -- History and Physical -- Syndromic Associations", "content": "L\u00f6fgren syndrome: It manifests as a triad of polyarthritis, erythema nodosum, and hilar lymphadenopathy. Other features include fever, malaise, uveitis, and parotitis. [60] Heerfordt-Waldenstr\u00f6m syndrome (uveoparotid fever ): It manifests as swelling of the parotid gland, fever, uveitis, and facial nerve palsy. [61]", "contents": "Ocular Sarcoidosis -- History and Physical -- Syndromic Associations. L\u00f6fgren syndrome: It manifests as a triad of polyarthritis, erythema nodosum, and hilar lymphadenopathy. Other features include fever, malaise, uveitis, and parotitis. [60] Heerfordt-Waldenstr\u00f6m syndrome (uveoparotid fever ): It manifests as swelling of the parotid gland, fever, uveitis, and facial nerve palsy. [61]"}
{"id": "article-140077_34", "title": "Ocular Sarcoidosis -- History and Physical -- Syndromic Associations", "content": "Blau syndrome: It is an autosomal dominant disorder seen in children below the age of 4 years. Clinical features include arthritis, rash, and uveitis. [62] Other names of the disease (OMIM #186580) include familial juvenile systemic granulomatosis,\u00a0early-onset sarcoidosis, Jabs syndrome, granulomatous inflammatory arthritis, dermatitis, and uveitis. There is a mutation in the NOD2 (or CARD15) gene at chromosome\u00a016q12.1.", "contents": "Ocular Sarcoidosis -- History and Physical -- Syndromic Associations. Blau syndrome: It is an autosomal dominant disorder seen in children below the age of 4 years. Clinical features include arthritis, rash, and uveitis. [62] Other names of the disease (OMIM #186580) include familial juvenile systemic granulomatosis,\u00a0early-onset sarcoidosis, Jabs syndrome, granulomatous inflammatory arthritis, dermatitis, and uveitis. There is a mutation in the NOD2 (or CARD15) gene at chromosome\u00a016q12.1."}
{"id": "article-140077_35", "title": "Ocular Sarcoidosis -- Evaluation", "content": "For diagnosis of ocular sarcoidosis, three criteria must be met: The patient must have clinical findings consistent with sarcoidosis as per the international workshop on ocular sarcoidosis (IWOS) criteria [Figure 4] Evidence of non-caseating granuloma on tissue biopsy Other causes of granulomatous inflammation (such as tuberculosis syphilis) should be ruled out. [63] The revised IWOS criteria for diagnosing ocular sarcoidosis [Figure 5] have removed the diagnosis of 'possible ocular sarcoidosis.' [22]", "contents": "Ocular Sarcoidosis -- Evaluation. For diagnosis of ocular sarcoidosis, three criteria must be met: The patient must have clinical findings consistent with sarcoidosis as per the international workshop on ocular sarcoidosis (IWOS) criteria [Figure 4] Evidence of non-caseating granuloma on tissue biopsy Other causes of granulomatous inflammation (such as tuberculosis syphilis) should be ruled out. [63] The revised IWOS criteria for diagnosing ocular sarcoidosis [Figure 5] have removed the diagnosis of 'possible ocular sarcoidosis.' [22]"}
{"id": "article-140077_36", "title": "Ocular Sarcoidosis -- Evaluation", "content": "The gold standard investigation in the diagnosis of sarcoidosis is tissue biopsy. In ocular sarcoidosis, tissue biopsy can be done on tissues including the eyelids, lacrimal glands, conjunctival nodules, and orbital tissues. However, at certain sites where tissue biopsy is not possible, imaging techniques such as chest x-ray, chest CT scan, serum angiotensin-converting enzyme (ACE) levels, serum calcium levels, and serum lysozyme levels may aid in the diagnosis of a probable or presumed ocular sarcoidosis. [63]", "contents": "Ocular Sarcoidosis -- Evaluation. The gold standard investigation in the diagnosis of sarcoidosis is tissue biopsy. In ocular sarcoidosis, tissue biopsy can be done on tissues including the eyelids, lacrimal glands, conjunctival nodules, and orbital tissues. However, at certain sites where tissue biopsy is not possible, imaging techniques such as chest x-ray, chest CT scan, serum angiotensin-converting enzyme (ACE) levels, serum calcium levels, and serum lysozyme levels may aid in the diagnosis of a probable or presumed ocular sarcoidosis. [63]"}
{"id": "article-140077_37", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Fundus photography -\u00a0 Helps document retinal findings and future objective comparisons of the lesions. Yellowish-white choroidal granulomas, periphlebitis, and other features of posterior uveitis can be documented as well as monitored on serial photographs. [64]", "contents": "Ocular Sarcoidosis -- Evaluation. Fundus photography -\u00a0 Helps document retinal findings and future objective comparisons of the lesions. Yellowish-white choroidal granulomas, periphlebitis, and other features of posterior uveitis can be documented as well as monitored on serial photographs. [64]"}
{"id": "article-140077_38", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Fundus fluorescein angiography (FFA) \u2013 FFA helps in documenting retinal vasculitis and detection of peripheral retinal neovascularization. [65] [66] FFA can reveal multiple retinal arterial macroaneurysms in an inflamed eye with or without optic disc granuloma, typical of ocular sarcoidosis. [67]", "contents": "Ocular Sarcoidosis -- Evaluation. Fundus fluorescein angiography (FFA) \u2013 FFA helps in documenting retinal vasculitis and detection of peripheral retinal neovascularization. [65] [66] FFA can reveal multiple retinal arterial macroaneurysms in an inflamed eye with or without optic disc granuloma, typical of ocular sarcoidosis. [67]"}
{"id": "article-140077_39", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Fundus autofluorescence imaging (FAF) \u2013 FAF helps detect sub-clinical retinal pigment epithelial changes in chorioretinal pathologies and monitors treatment response in uveitis patients with chorioretinal lesions. [68]", "contents": "Ocular Sarcoidosis -- Evaluation. Fundus autofluorescence imaging (FAF) \u2013 FAF helps detect sub-clinical retinal pigment epithelial changes in chorioretinal pathologies and monitors treatment response in uveitis patients with chorioretinal lesions. [68]"}
{"id": "article-140077_40", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Optical coherence tomography (OCT) \u2013 OCT helps assess and monitor macular edema and helps predict functional outcomes based on the structural integrity of various retinal layers. [69] Enhanced depth OCT imaging can be useful in the detection of choroidal granulomas. [70]", "contents": "Ocular Sarcoidosis -- Evaluation. Optical coherence tomography (OCT) \u2013 OCT helps assess and monitor macular edema and helps predict functional outcomes based on the structural integrity of various retinal layers. [69] Enhanced depth OCT imaging can be useful in the detection of choroidal granulomas. [70]"}
{"id": "article-140077_41", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Anterior segment OCT\u00a0 \u2013 Anterior segment OCT helps identify and document peripheral anterior synechiae and the extent of angle closure. [71] In cases with granulomatous uveitis, it shows hyperreflective dots in the aqueous humor and on the posterior corneal surface. [72]", "contents": "Ocular Sarcoidosis -- Evaluation. Anterior segment OCT\u00a0 \u2013 Anterior segment OCT helps identify and document peripheral anterior synechiae and the extent of angle closure. [71] In cases with granulomatous uveitis, it shows hyperreflective dots in the aqueous humor and on the posterior corneal surface. [72]"}
{"id": "article-140077_42", "title": "Ocular Sarcoidosis -- Evaluation", "content": "OCT of the optic nerve \u2013 OCT of the optic nerve head helps investigate an optic nerve head granuloma.\u00a0It helps detect adjacent peripapillary retinal edema, monitor response to treatment, and evaluate the severity of optic nerve damage due to glaucoma. [73] [74]", "contents": "Ocular Sarcoidosis -- Evaluation. OCT of the optic nerve \u2013 OCT of the optic nerve head helps investigate an optic nerve head granuloma.\u00a0It helps detect adjacent peripapillary retinal edema, monitor response to treatment, and evaluate the severity of optic nerve damage due to glaucoma. [73] [74]"}
{"id": "article-140077_43", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Ultrasonography of the eye \u2013 In patients with vitreous hemorrhage secondary to sarcoidosis, ultrasonography of the eye helps to understand the status of the retina. It helps as pre-operative aid in assessing the status of posterior vitreous detachment.", "contents": "Ocular Sarcoidosis -- Evaluation. Ultrasonography of the eye \u2013 In patients with vitreous hemorrhage secondary to sarcoidosis, ultrasonography of the eye helps to understand the status of the retina. It helps as pre-operative aid in assessing the status of posterior vitreous detachment."}
{"id": "article-140077_44", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Ultrasound biomicroscopy (UBM) - UBM helps objectively evaluate the inflammatory process in anterior chamber angle, iris, ciliary body, pars plana, and peripheral vitreous. [75] It helps in the evaluation of ocular hypotony in cases of uveitis. [76]", "contents": "Ocular Sarcoidosis -- Evaluation. Ultrasound biomicroscopy (UBM) - UBM helps objectively evaluate the inflammatory process in anterior chamber angle, iris, ciliary body, pars plana, and peripheral vitreous. [75] It helps in the evaluation of ocular hypotony in cases of uveitis. [76]"}
{"id": "article-140077_45", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Visual fields \u2013 A wide range of visual field defects can be seen either due to glaucomatous optic neuropathy or ischemic optic neuropathy. Patients with ischemic optic neuropathy can present with central or centrocecal scotomas, hemianopic field defect, or altitudinal field defect. [77]", "contents": "Ocular Sarcoidosis -- Evaluation. Visual fields \u2013 A wide range of visual field defects can be seen either due to glaucomatous optic neuropathy or ischemic optic neuropathy. Patients with ischemic optic neuropathy can present with central or centrocecal scotomas, hemianopic field defect, or altitudinal field defect. [77]"}
{"id": "article-140077_46", "title": "Ocular Sarcoidosis -- Evaluation", "content": "Diagnostic vitrectomy \u2013 In limited cases, the vitreous sample obtained by vitrectomy can be used for diagnostic analysis. High mobility group box -1 (HMGB1), a pro-inflammatory cytokine, is detected in high levels in the vitreous of patients with ocular sarcoidosis. [78]", "contents": "Ocular Sarcoidosis -- Evaluation. Diagnostic vitrectomy \u2013 In limited cases, the vitreous sample obtained by vitrectomy can be used for diagnostic analysis. High mobility group box -1 (HMGB1), a pro-inflammatory cytokine, is detected in high levels in the vitreous of patients with ocular sarcoidosis. [78]"}
{"id": "article-140077_47", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Chest X-ray \u2013 Bilateral hilar lymphadenopathy is the classical radiological feature of sarcoidosis. [79] Lung parenchymal infiltrates appear in around 20 to 50% of the patients. [80] Lung volume loss, hilar retraction, and linear opaque bands may be seen when lung fibrosis occurs. [81]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Chest X-ray \u2013 Bilateral hilar lymphadenopathy is the classical radiological feature of sarcoidosis. [79] Lung parenchymal infiltrates appear in around 20 to 50% of the patients. [80] Lung volume loss, hilar retraction, and linear opaque bands may be seen when lung fibrosis occurs. [81]"}
{"id": "article-140077_48", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "High resolution computed tomography (HRCT) chest \u2013 HRCT scans are superior to conventional chest X-rays in delineating hilar lymphadenopathy, understanding lung parenchymal damage, and differentiating inflammation from fibrosis. [82] Characteristic features of HRCT chest in sarcoidosis include mediastinal lymphadenopathy, lung parenchymal nodular opacities, nodular opacities\u00a0at the bronchovascular bundles, predominant involvement of mid or upper lung zones, and ground-glass opacities. [83]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. High resolution computed tomography (HRCT) chest \u2013 HRCT scans are superior to conventional chest X-rays in delineating hilar lymphadenopathy, understanding lung parenchymal damage, and differentiating inflammation from fibrosis. [82] Characteristic features of HRCT chest in sarcoidosis include mediastinal lymphadenopathy, lung parenchymal nodular opacities, nodular opacities\u00a0at the bronchovascular bundles, predominant involvement of mid or upper lung zones, and ground-glass opacities. [83]"}
{"id": "article-140077_49", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Pulmonary function tests \u2013 Pulmonary function tests typically reveal a restrictive pattern of ventilatory function. The tests show decreased lung volume and decreased carbon monoxide diffusing capacity. [84]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Pulmonary function tests \u2013 Pulmonary function tests typically reveal a restrictive pattern of ventilatory function. The tests show decreased lung volume and decreased carbon monoxide diffusing capacity. [84]"}
{"id": "article-140077_50", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Serum angiotensin-converting enzyme (SACE) assay \u2013 SACE levels are elevated in about 30 to 80% of patients with sarcoidosis. [85] However, about 20% of patients show false positive elevated levels of SACE.\u00a0SACE may also be normal in patients with active disease.", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Serum angiotensin-converting enzyme (SACE) assay \u2013 SACE levels are elevated in about 30 to 80% of patients with sarcoidosis. [85] However, about 20% of patients show false positive elevated levels of SACE.\u00a0SACE may also be normal in patients with active disease."}
{"id": "article-140077_51", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Bronchoalveolar lavage (BAL) \u2013 BAL fluid analysis shows an increased number of activated T lymphocytes, alveolar macrophages, and inflammatory cytokines. In 85% of patients with pulmonary sarcoidosis, lymphocytosis is seen with normal or low granulocyte count. [86] However, the BAL cell profile is not specific for sarcoidosis. [87]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Bronchoalveolar lavage (BAL) \u2013 BAL fluid analysis shows an increased number of activated T lymphocytes, alveolar macrophages, and inflammatory cytokines. In 85% of patients with pulmonary sarcoidosis, lymphocytosis is seen with normal or low granulocyte count. [86] However, the BAL cell profile is not specific for sarcoidosis. [87]"}
{"id": "article-140077_52", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Radionuclide techniques \u2013 Radionuclide techniques include Gallium (Ga) scans fluoro-2deoxy-glucose (FDG) positron emission tomography (PET) scans. Uptake of Gallium helps identify appropriate sites to take the biopsy. [88] The uptake of Gallium by intrathoracic lymph nodes resembles the Greek letter lambda (Lambda sign), and uptake in bilateral parotid and lacrimal gland resembles a panda face (Panda sign). [89] PET scan helps identify lung activity in pulmonary disease and sarcoidosis activity at non-pulmonary sites such as bone, cardiac, and the nervous system. [90] [91] [92] [93]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Radionuclide techniques \u2013 Radionuclide techniques include Gallium (Ga) scans fluoro-2deoxy-glucose (FDG) positron emission tomography (PET) scans. Uptake of Gallium helps identify appropriate sites to take the biopsy. [88] The uptake of Gallium by intrathoracic lymph nodes resembles the Greek letter lambda (Lambda sign), and uptake in bilateral parotid and lacrimal gland resembles a panda face (Panda sign). [89] PET scan helps identify lung activity in pulmonary disease and sarcoidosis activity at non-pulmonary sites such as bone, cardiac, and the nervous system. [90] [91] [92] [93]"}
{"id": "article-140077_53", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Lung Biopsy \u2013 Transbronchial lung biopsy (TBLB) using a flexible fiberoptic bronchoscopy (FFB) is the diagnostic procedure of choice in patients with pulmonary sarcoidosis with a sensitivity range of 60 to 90% depending on the stage of the disease. [94] In the presence of lymphadenopathy, transbronchial needle aspiration (TBNA) biopsies are diagnostic in 63 to 90% of cases. [95] [96] Biopsy shows the presence of non-caseating granulomas.", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Lung Biopsy \u2013 Transbronchial lung biopsy (TBLB) using a flexible fiberoptic bronchoscopy (FFB) is the diagnostic procedure of choice in patients with pulmonary sarcoidosis with a sensitivity range of 60 to 90% depending on the stage of the disease. [94] In the presence of lymphadenopathy, transbronchial needle aspiration (TBNA) biopsies are diagnostic in 63 to 90% of cases. [95] [96] Biopsy shows the presence of non-caseating granulomas."}
{"id": "article-140077_54", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "Kveim-Siltzbach test \u2013 This test involves intradermal injection of a suspension of granuloma containing spleen or lymph node from a patient with sarcoidosis. [97] A positive test shows the development of papule at the injection site within 4-6 weeks, which on biopsy shows non-caseating granuloma. [98] This test is now vaguely in use and is of historical interest. [99]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. Kveim-Siltzbach test \u2013 This test involves intradermal injection of a suspension of granuloma containing spleen or lymph node from a patient with sarcoidosis. [97] A positive test shows the development of papule at the injection site within 4-6 weeks, which on biopsy shows non-caseating granuloma. [98] This test is now vaguely in use and is of historical interest. [99]"}
{"id": "article-140077_55", "title": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations", "content": "MRI (magnetic resonance imaging) of the brain \u2013 MRI brain in neurosarcoidosis reveals a wide spectrum of findings such as periventricular and white matter lesions, leptomeningeal enhancement, solitary or multiple supra- and infratentorial brain lesions, and involvement of cranial nerves. [100]", "contents": "Ocular Sarcoidosis -- Evaluation -- Systemic Investigations. MRI (magnetic resonance imaging) of the brain \u2013 MRI brain in neurosarcoidosis reveals a wide spectrum of findings such as periventricular and white matter lesions, leptomeningeal enhancement, solitary or multiple supra- and infratentorial brain lesions, and involvement of cranial nerves. [100]"}
{"id": "article-140077_56", "title": "Ocular Sarcoidosis -- Treatment / Management -- Corticosteroids", "content": "Corticosteroids are potent anti-inflammatory agents used in the management of uveitis.\u00a0They can be used topically as eye drops to treat anterior uveitis. However,\u00a0topical steroids are insufficient in the control of posterior uveitis. The most commonly used topical corticosteroids are prednisolone acetate 1% or difluprednate 0.05%. [101]", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Corticosteroids. Corticosteroids are potent anti-inflammatory agents used in the management of uveitis.\u00a0They can be used topically as eye drops to treat anterior uveitis. However,\u00a0topical steroids are insufficient in the control of posterior uveitis. The most commonly used topical corticosteroids are prednisolone acetate 1% or difluprednate 0.05%. [101]"}
{"id": "article-140077_57", "title": "Ocular Sarcoidosis -- Treatment / Management -- Regional corticosteroids", "content": "These agents are used in cases of posterior uveitis or when the patient is poorly compliant to frequent dosages of topical corticosteroids. They can be given as posterior subtenon injection in a dose of 20\u00a0to 40 mg of triamcinolone acetonide\u00a0or intravitreal injection of 1\u00a0to 4 mg of triamcinolone acetonide. [102] [103] [102]", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Regional corticosteroids. These agents are used in cases of posterior uveitis or when the patient is poorly compliant to frequent dosages of topical corticosteroids. They can be given as posterior subtenon injection in a dose of 20\u00a0to 40 mg of triamcinolone acetonide\u00a0or intravitreal injection of 1\u00a0to 4 mg of triamcinolone acetonide. [102] [103] [102]"}
{"id": "article-140077_58", "title": "Ocular Sarcoidosis -- Treatment / Management -- Regional corticosteroids", "content": "Long-acting sustained slow release steroid implants such as 0.7 mg of dexamethasone, 0.19 mg of fluocinolone acetonide, or 0.59 mg of fluocinolone acetonide\u00a0provide longer periods of anti-inflammatory effect. The regional corticosteroids may cause glaucoma and cataracts, and thus the patients should be observed closely and promptly treated for the complications. [104] [105] [104]", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Regional corticosteroids. Long-acting sustained slow release steroid implants such as 0.7 mg of dexamethasone, 0.19 mg of fluocinolone acetonide, or 0.59 mg of fluocinolone acetonide\u00a0provide longer periods of anti-inflammatory effect. The regional corticosteroids may cause glaucoma and cataracts, and thus the patients should be observed closely and promptly treated for the complications. [104] [105] [104]"}
{"id": "article-140077_59", "title": "Ocular Sarcoidosis -- Treatment / Management -- Systemic steroids", "content": "Systemically dosed steroids are used in cases of bilateral uveitis with systemic involvement or when there is poor disease control with local steroid use. Prednisolone in the dose of 1\u00a0to 1.5 mg/kg/day initially followed by slow tapering is the usual treatment protocol.", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Systemic steroids. Systemically dosed steroids are used in cases of bilateral uveitis with systemic involvement or when there is poor disease control with local steroid use. Prednisolone in the dose of 1\u00a0to 1.5 mg/kg/day initially followed by slow tapering is the usual treatment protocol."}
{"id": "article-140077_60", "title": "Ocular Sarcoidosis -- Treatment / Management -- Cycloplegic Agents", "content": "These agents are used to relieve ciliary spasms and associated ocular pain. They help in breaking or preventing posterior synechiae. Commonly used agents include cyclopentolate 1%, homatropine 2%, and atropine 1%.", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Cycloplegic Agents. These agents are used to relieve ciliary spasms and associated ocular pain. They help in breaking or preventing posterior synechiae. Commonly used agents include cyclopentolate 1%, homatropine 2%, and atropine 1%."}
{"id": "article-140077_61", "title": "Ocular Sarcoidosis -- Treatment / Management -- Systemic Immunosuppressive Agents", "content": "These agents are used in cases of corticosteroid-resistant cases or steroid-dependent cases where the side effects of the steroid regimen outweigh the anti-inflammatory effects. Most commonly used agents for the treatment of non-infectious uveitis are methotrexate\u00a0(7.5\u00a0to 25 mg /week; oral, subcutaneous, or intramuscular route), mycophenolate mofetil\u00a0(500\u20131500 mg bd; oral route), cyclosporine\u00a0(2.5\u00a0to 10 mg/kg/day bd; oral route), and azathioprine\u00a0(1\u00a0to 4 mg/kg/day; oral route). [106] [107] [108]", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Systemic Immunosuppressive Agents. These agents are used in cases of corticosteroid-resistant cases or steroid-dependent cases where the side effects of the steroid regimen outweigh the anti-inflammatory effects. Most commonly used agents for the treatment of non-infectious uveitis are methotrexate\u00a0(7.5\u00a0to 25 mg /week; oral, subcutaneous, or intramuscular route), mycophenolate mofetil\u00a0(500\u20131500 mg bd; oral route), cyclosporine\u00a0(2.5\u00a0to 10 mg/kg/day bd; oral route), and azathioprine\u00a0(1\u00a0to 4 mg/kg/day; oral route). [106] [107] [108]"}
{"id": "article-140077_62", "title": "Ocular Sarcoidosis -- Treatment / Management -- Biologic Agents", "content": "These are used in cases of refractory non-infectious uveitis. The most commonly used biologic agents are tumor necrosis factor-alpha inhibitors (TNF \u03b1) such as infliximab, adalimumab, etanercept, and golimumab. These agents promise to offer a new option in resistant cases. The patient should be tested for latent tuberculosis and hepatitis B before starting biologic agents to prevent the reactivation of infection. [109] Interestingly, a 'sarcoid-like granulomatosis' has been reported following anti-TNF\u00a0therapy, including etanercept, infliximab, and adalimumab for various indications, including rheumatoid arthritis and spondyloarthritis. [110]", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Biologic Agents. These are used in cases of refractory non-infectious uveitis. The most commonly used biologic agents are tumor necrosis factor-alpha inhibitors (TNF \u03b1) such as infliximab, adalimumab, etanercept, and golimumab. These agents promise to offer a new option in resistant cases. The patient should be tested for latent tuberculosis and hepatitis B before starting biologic agents to prevent the reactivation of infection. [109] Interestingly, a 'sarcoid-like granulomatosis' has been reported following anti-TNF\u00a0therapy, including etanercept, infliximab, and adalimumab for various indications, including rheumatoid arthritis and spondyloarthritis. [110]"}
{"id": "article-140077_63", "title": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Orbital Disease", "content": "Orbital inflammation is typically amenable to systemic steroids or immunosuppressive agents.\u00a0In cases with chronic eyelid or lacrimal gland swelling, a biopsy is\u00a0necessary to differentiate it from tumors.", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Orbital Disease. Orbital inflammation is typically amenable to systemic steroids or immunosuppressive agents.\u00a0In cases with chronic eyelid or lacrimal gland swelling, a biopsy is\u00a0necessary to differentiate it from tumors."}
{"id": "article-140077_64", "title": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Ocular Surface Disease", "content": "Conjunctival lesions and KCS usually responds to topical cyclosporine eye drops. [111] For scleritis, initial treatment is with systemic non-steroidal anti-inflammatory drugs (NSAIDs), with steroids and immunosuppressants reserved for resistant cases.", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Ocular Surface Disease. Conjunctival lesions and KCS usually responds to topical cyclosporine eye drops. [111] For scleritis, initial treatment is with systemic non-steroidal anti-inflammatory drugs (NSAIDs), with steroids and immunosuppressants reserved for resistant cases."}
{"id": "article-140077_65", "title": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Ocular Complications", "content": "Glaucoma is one of the most common uveitis complications and a serious side effect of chronic corticosteroid use. Glaucoma needs to be monitored at each visit and requires early intervention either medically or surgically. Cataract surgery is usually planned after three months of disease inactivity. Uveitic cystoid macular edema is one of the common causes of ocular morbidity and requires intervention in the form of anti-inflammatory agents.", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Ocular Complications. Glaucoma is one of the most common uveitis complications and a serious side effect of chronic corticosteroid use. Glaucoma needs to be monitored at each visit and requires early intervention either medically or surgically. Cataract surgery is usually planned after three months of disease inactivity. Uveitic cystoid macular edema is one of the common causes of ocular morbidity and requires intervention in the form of anti-inflammatory agents."}
{"id": "article-140077_66", "title": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Ocular Complications", "content": "In certain cases, posterior subtenon triamcinolone, intravitreal injection of steroids (triamcinolone, dexamethasone implant, or fluocinolone implant), or anti-VEGF (vascular endothelial growth factor) agents like bevacizumab\u00a0or ranibizumab\u00a0are required to control cystoid macular edema. Development of epiretinal membrane at the macula, vitreomacular traction, and vitreous hemorrhage may warrant surgical intervention in the form of vitrectomy. [112] [113]", "contents": "Ocular Sarcoidosis -- Treatment / Management -- Treatment of Ocular Complications. In certain cases, posterior subtenon triamcinolone, intravitreal injection of steroids (triamcinolone, dexamethasone implant, or fluocinolone implant), or anti-VEGF (vascular endothelial growth factor) agents like bevacizumab\u00a0or ranibizumab\u00a0are required to control cystoid macular edema. Development of epiretinal membrane at the macula, vitreomacular traction, and vitreous hemorrhage may warrant surgical intervention in the form of vitrectomy. [112] [113]"}
{"id": "article-140077_67", "title": "Ocular Sarcoidosis -- Differential Diagnosis", "content": "Sarcoidosis is a disease that can simultaneously involve various parts of the eye with multiple presentations.\u00a0Differential diagnoses should be considered for various ocular findings, including iris nodules, intermediate uveitis, chorioretinitis,\u00a0retinitis,\u00a0choroidal infiltrates, dacryoadenopathy, and peripheral retinal neovascularization. [114] The most common differential diagnoses to be considered include: Iris nodules : Iris nodules may also be seen in inflammatory conditions such as tuberculosis, leprosy, and syphilis, tumors of the iris, and infiltration by retinoblastoma. Intermediate uveitis : Intermediate uveitis may also be idiopathic or seen in Lyme disease, tuberculosis, and multiple sclerosis. Chorioretinitis : Chorioretinitis may also be seen in tuberculosis, histoplasmosis, toxoplasmosis, and syphilis.", "contents": "Ocular Sarcoidosis -- Differential Diagnosis. Sarcoidosis is a disease that can simultaneously involve various parts of the eye with multiple presentations.\u00a0Differential diagnoses should be considered for various ocular findings, including iris nodules, intermediate uveitis, chorioretinitis,\u00a0retinitis,\u00a0choroidal infiltrates, dacryoadenopathy, and peripheral retinal neovascularization. [114] The most common differential diagnoses to be considered include: Iris nodules : Iris nodules may also be seen in inflammatory conditions such as tuberculosis, leprosy, and syphilis, tumors of the iris, and infiltration by retinoblastoma. Intermediate uveitis : Intermediate uveitis may also be idiopathic or seen in Lyme disease, tuberculosis, and multiple sclerosis. Chorioretinitis : Chorioretinitis may also be seen in tuberculosis, histoplasmosis, toxoplasmosis, and syphilis."}
{"id": "article-140077_68", "title": "Ocular Sarcoidosis -- Differential Diagnosis", "content": "Choroidal infiltrates : \u00a0Choroidal infiltrates may also be\u00a0present in white dot syndromes such as acute posterior multifocal placoid pigment epitheliopathy, birdshot choroidopathy; Vogt-Koyanagi-Harada disease, amelanotic melanoma, and metastatic infiltrates. Dacryoadenopathy: Dacryoadenopathy may also be seen in tuberculosis, brucellosis, Hodgkin's lymphoma, and parotid gland tumors. Peripheral retinal neovascularization: Peripheral retinal neovascularization may also be\u00a0present in diabetic retinopathy,\u00a0vein occlusions, sickle cell retinopathy, and Eales disease. [115] [116]", "contents": "Ocular Sarcoidosis -- Differential Diagnosis. Choroidal infiltrates : \u00a0Choroidal infiltrates may also be\u00a0present in white dot syndromes such as acute posterior multifocal placoid pigment epitheliopathy, birdshot choroidopathy; Vogt-Koyanagi-Harada disease, amelanotic melanoma, and metastatic infiltrates. Dacryoadenopathy: Dacryoadenopathy may also be seen in tuberculosis, brucellosis, Hodgkin's lymphoma, and parotid gland tumors. Peripheral retinal neovascularization: Peripheral retinal neovascularization may also be\u00a0present in diabetic retinopathy,\u00a0vein occlusions, sickle cell retinopathy, and Eales disease. [115] [116]"}
{"id": "article-140077_69", "title": "Ocular Sarcoidosis -- Staging", "content": "On chest X-ray posteroanterior (PA) view, the pulmonary disease\u00a0is divided into five stages: Stage 0: Unremarkable chest X-ray Stage I: Enlargement of the hilar or mediastinal lymph nodes Stage II: Parenchymal disease along with\u00a0enlargement of the lymph nodes Stage III: Only parenchymal disease Stage IV: Pulmonary fibrosis or end-stage lung disease [117] [118]", "contents": "Ocular Sarcoidosis -- Staging. On chest X-ray posteroanterior (PA) view, the pulmonary disease\u00a0is divided into five stages: Stage 0: Unremarkable chest X-ray Stage I: Enlargement of the hilar or mediastinal lymph nodes Stage II: Parenchymal disease along with\u00a0enlargement of the lymph nodes Stage III: Only parenchymal disease Stage IV: Pulmonary fibrosis or end-stage lung disease [117] [118]"}
{"id": "article-140077_70", "title": "Ocular Sarcoidosis -- Prognosis", "content": "Outcomes in\u00a0cases of ocular sarcoidosis depend on several variables such as the severity of disease, chronicity of disease, time of presentation to healthcare facilities, and secondary complications due to long-standing ocular inflammation. [46] The overall prognosis for ocular sarcoidosis is usually good, and most patients recover without significant functional damage. [119]", "contents": "Ocular Sarcoidosis -- Prognosis. Outcomes in\u00a0cases of ocular sarcoidosis depend on several variables such as the severity of disease, chronicity of disease, time of presentation to healthcare facilities, and secondary complications due to long-standing ocular inflammation. [46] The overall prognosis for ocular sarcoidosis is usually good, and most patients recover without significant functional damage. [119]"}
{"id": "article-140077_71", "title": "Ocular Sarcoidosis -- Prognosis", "content": "Irreversible loss of vision usually occurs due to glaucoma and chronic maculopathy.\u00a0In a prospective study by Edelsten et al., it was noted that the prognosis of sarcoid uveitis is not affected by extraocular disease.\u00a0The presence of the HLA DQB1*0201 allele is proven to be protective against severe sarcoidosis. [120]", "contents": "Ocular Sarcoidosis -- Prognosis. Irreversible loss of vision usually occurs due to glaucoma and chronic maculopathy.\u00a0In a prospective study by Edelsten et al., it was noted that the prognosis of sarcoid uveitis is not affected by extraocular disease.\u00a0The presence of the HLA DQB1*0201 allele is proven to be protective against severe sarcoidosis. [120]"}
{"id": "article-140077_72", "title": "Ocular Sarcoidosis -- Prognosis", "content": "Prognostic factors for poor visual outcomes include black race, delayed presentation to a subspecialist, glaucoma, intermediate or posterior uveitis, cystoid macular edema, and use of systemic steroids.\u00a0The overall mortality from sarcoidosis may reach 5% or even 10% with neurosarcoidosis. Poor prognostic factors in sarcoidosis include female gender (compared to male), early-onset disease, African-American ethnicity, chronic sarcoidosis, Annexin A11 gene, HLA-DQB1*1501, HLA-DQB1*0602, pulmonary fibrosis, poor pulmonary function test, optic nerve involvement, panuveitis, lupus pernio, chronic arthritis, and stage 3 or 4 of the disease in radiography. [121]", "contents": "Ocular Sarcoidosis -- Prognosis. Prognostic factors for poor visual outcomes include black race, delayed presentation to a subspecialist, glaucoma, intermediate or posterior uveitis, cystoid macular edema, and use of systemic steroids.\u00a0The overall mortality from sarcoidosis may reach 5% or even 10% with neurosarcoidosis. Poor prognostic factors in sarcoidosis include female gender (compared to male), early-onset disease, African-American ethnicity, chronic sarcoidosis, Annexin A11 gene, HLA-DQB1*1501, HLA-DQB1*0602, pulmonary fibrosis, poor pulmonary function test, optic nerve involvement, panuveitis, lupus pernio, chronic arthritis, and stage 3 or 4 of the disease in radiography. [121]"}
{"id": "article-140077_73", "title": "Ocular Sarcoidosis -- Complications -- Ocular Complications", "content": "Glaucoma Cataract Central retinal artery occlusion Cystoid macular edema Epiretinal membrane Intraretinal hemorrhage Vitreous hemorrhage Phthisis [122]", "contents": "Ocular Sarcoidosis -- Complications -- Ocular Complications. Glaucoma Cataract Central retinal artery occlusion Cystoid macular edema Epiretinal membrane Intraretinal hemorrhage Vitreous hemorrhage Phthisis [122]"}
{"id": "article-140077_74", "title": "Ocular Sarcoidosis -- Complications -- Systemic Complications", "content": "Neurosarcoidosis Pulmonary hypertension End-stage lung damage", "contents": "Ocular Sarcoidosis -- Complications -- Systemic Complications. Neurosarcoidosis Pulmonary hypertension End-stage lung damage"}
{"id": "article-140077_75", "title": "Ocular Sarcoidosis -- Deterrence and Patient Education", "content": "Although ocular sarcoidosis can have an acute presentation with a limited course, some patients develop a chronic unrelenting form of the disease. [123] Patients with chronic disease should be made aware of complications due to chronic inflammation such as glaucoma, cataract, cystoid macular edema, and epiretinal membrane formation. Patients should also be made aware of the need for medical compliance and drug-related adverse effects. Patients with sarcoid uveitis are known to carry a risk of neurological involvement for at least the next 15 years. [124]", "contents": "Ocular Sarcoidosis -- Deterrence and Patient Education. Although ocular sarcoidosis can have an acute presentation with a limited course, some patients develop a chronic unrelenting form of the disease. [123] Patients with chronic disease should be made aware of complications due to chronic inflammation such as glaucoma, cataract, cystoid macular edema, and epiretinal membrane formation. Patients should also be made aware of the need for medical compliance and drug-related adverse effects. Patients with sarcoid uveitis are known to carry a risk of neurological involvement for at least the next 15 years. [124]"}
{"id": "article-140077_76", "title": "Ocular Sarcoidosis -- Enhancing Healthcare Team Outcomes", "content": "Sarcoidosis is a multisystem disease and requires effective coordination between an ophthalmologist, pulmonologist, infectious disease specialist, dermatologist, rheumatologist, radiologist, cardiologist, neurologist, and pharmacist. At each visit, an ophthalmic assistant should measure intraocular pressure in addition to vision, as both the disease and its treatment, i.e., steroids, can lead to raised intraocular pressure. The pharmacist plays a vital role in monitoring compliance to treatment and educating patients about the side effects of various drugs used in the treatment.\u00a0Clinical overlap between sarcoidosis and tuberculosis is not uncommon, and\u00a0an infectious disease specialist should be consulted in such cases. Nursing staff plays an important role in ensuring compliance with therapy. An optimal interprofessional collaboration can ensure the best outcomes in patients with ocular sarcoidosis.", "contents": "Ocular Sarcoidosis -- Enhancing Healthcare Team Outcomes. Sarcoidosis is a multisystem disease and requires effective coordination between an ophthalmologist, pulmonologist, infectious disease specialist, dermatologist, rheumatologist, radiologist, cardiologist, neurologist, and pharmacist. At each visit, an ophthalmic assistant should measure intraocular pressure in addition to vision, as both the disease and its treatment, i.e., steroids, can lead to raised intraocular pressure. The pharmacist plays a vital role in monitoring compliance to treatment and educating patients about the side effects of various drugs used in the treatment.\u00a0Clinical overlap between sarcoidosis and tuberculosis is not uncommon, and\u00a0an infectious disease specialist should be consulted in such cases. Nursing staff plays an important role in ensuring compliance with therapy. An optimal interprofessional collaboration can ensure the best outcomes in patients with ocular sarcoidosis."}
{"id": "article-140077_77", "title": "Ocular Sarcoidosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Ocular Sarcoidosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}